Skip to main content

Table 2 CO and RE cancer cell surface biomarkers based on integrated MCIA and recount2

From: Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy

log2FoldChange

pvalue

padj

receptor ID

Gene ID

Colon cancer: recount2 analysis filtered by MCIA hits

 

 0.659

6.844e−10

3.064e−9

CD49f

ITGA6

 0.503

1.923e−06

6.064e−06

CD15

FUT4

 0.328

0.016

0.029

CD104

ITGB4

 − 0.431

3.118e−06

9.609e−06

CD326

EPCAM

 − 0.489

2.994e−8

1.144e−7

CD324

CDH1

Renal cancer: recount2 analysis filtered by MCIA hits

 

 2.304

1.021e−36

1.237e−35

TIM1

HAVCR1

 1.726

4.503e−36

5.309e−35

CD106

VCAM1

 1.464

7.690e−63

2.500e−61

SSEA-4

TMCC1

 1.371

6.499e−11

2.119e−10

SSEA-3

B3GALT5

 1.200

1.296e−32

1.323e−31

EGFR

EGFR

 0.681

9.772e−7

2.383e−06

CD26

DPP4

 0.464

1.575e−8

4.375−8

CD24

CD24

 − 1.856

7.622e−41

1.1002e−39

TRA-1-60-R

PODXL